Γενικά > Αποσπάσματα από τον έντυπο και ηλεκτρονικό τύπο
Χαπάκωμα με ινδική κάνναβη
Argirios Argiriou:
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
BMJ 2023; 382 doi: Δεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή Είσοδος (Published 30 August 2023)
Cite this as: BMJ 2023;382:e072348
Conclusions: Convincing or converging evidence supports avoidance of cannabis during adolescence and early adulthood, in people prone to or with mental health disorders, in pregnancy and before and while driving. Cannabidiol is effective in people with epilepsy. Cannabis based medicines are effective in people with multiple sclerosis, chronic pain, inflammatory bowel disease, and in palliative medicine but not without adverse events.
Δεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή Είσοδος
Argirios Argiriou:
BMJ 2021
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
BMJ 2021; 374 doi: Δεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή Είσοδος (Published 09 September 2021)
Conclusions: Moderate to high certainty evidence shows that non-inhaled medical cannabis or cannabinoids results in a small to very small improvement in pain relief, physical functioning, and sleep quality among patients with chronic pain, along with several transient adverse side effects, compared with placebo.The accompanying BMJ Rapid Recommendation provides contextualised guidance based on this body of evidence.
Δεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή Είσοδος
Πλοήγηση
[0] Λίστα μηνυμάτων
Μετάβαση στην πλήρη έκδοση